- Mohamed bin Hadi Al Hussaini: The tap issuances reaffirm the Ministry of Finance’s continued support for the UAE Government’s Islamic Treasury Sukuk Programme
- Nasdaq Dubai continues to consolidate its position as a leading global hub for Islamic finance, with total outstanding Sukuk at USD 99.4 billion
- Abdul Wahed Al Fahim: Strong demand for Islamic Treasury Sukuk demonstrates the strength and sustained growth of the UAE economy
- Hamed Ali: UAE Government Islamic Treasury Sukuk issuances reflect the strength of the country’s Islamic finance ecosystem
Monthly Archives: April 2026
Arcera Life Sciences and Fosun Pharma launch long-term collaboration framework
- Strategic framework established for regional and global licensing, frontier technology incubation, and strategic collaboration in neurodegenerative diseases
- Joint R&D aligned with China-UAE bilateral partnership and Abu Dhabi’s Healthcare Life Sciences Vision 2030
Abu Dhabi, United Arab Emirates and Shanghai, China, April 28, 2026 – Arcera Life Sciences (“Arcera”), a global life sciences company headquartered in Abu Dhabi, and Shanghai Fosun Pharmaceutical Group Co., Ltd. (“Fosun Pharma”), an innovation-driven global pharmaceutical and healthcare group, today announced the signing of a Memorandum of Understanding (MoU) to establish a long-term strategic collaboration focused on licensing, technology development, neuroscience innovation and value creation in the global life sciences sector.
The agreement was executed by Sunil Bhilotra, Chief Investment Officer of Arcera, and Xingli Wang, Co-President of Fosun Pharma, CEO of Innovative Medicines Division in Shanghai, China. The signing ceremony was witnessed by Qunbin Wang, Co-Chairman of Fosun International; Yuqing Chen, Chairman of Fosun Pharma; Isabel Afonso, Chief Executive Officer of Arcera; and Rafael Ferrer, SVP Corporate Development of Arcera.
Continue reading Arcera Life Sciences and Fosun Pharma launch long-term collaboration framework
NMDC Energy Reports AED 80M Net Profit for Q1 2026
- Net profit of AED 80 million in Q1 2026
- NMDC Energy maintained a strong liquidity position, with a cash balance of AED 3.5 billion
Abu Dhabi, UAE; 28th April 2026: NMDC Energy (ADX: NMDCENR), a leading provider of engineering, procurement and construction (EPC) services for offshore and onshore energy clients, today announced its financial results for the first quarter of 2026, recording revenue growth despite current regional conditions.
PureHealth Achieves AAHRPP Accreditation for Clinical Research
Abu Dhabi, 28 April 2026: PureHealth, the largest healthcare group in the Middle East, has achieved full accreditation from the Association for the Accreditation of Human Research Protection Programs (AAHRPP) for its SEHA and Sheikh Shakhbout Medical City (SSMC) entities, recognising the strength of the group’s clinical research capabilities.
The research divisions of both entities operate under the Abu Dhabi Health Research Centre (ADHRC), PureHealth’s integrated clinical research hub, which consolidates activity across 16 hospitals, primary care clinics and advanced laboratories in Abu Dhabi. With more than 200 active studies spanning early and advanced clinical trials, as well as translational research, ADHRC is underpinned by a unified governance framework that strengthens oversight and enables high-quality research at scale.
How UAE’s Capital Markets Can Transform Family Businesses
UAE businesses could benefit from GCC capital markets where Assets under Management hits US$2.2 trn, experts at an ICAI conference says
Innovation and transformation will create new opportunities for accounting professionals in the UAE where members of the Institute of Chartered Accountants of India could lead the changes by accessing the capital markets
UAE News 24/7 